Characteristics of patients with type 2 diabetes mellitus (CVD-RNDR)
Study identifier:D1690R00048
ClinicalTrials.gov identifier:NCT03694470
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Retrospective study to describe characteristics of patients with type 2 diabetes mellitus who were initiating use or treatment with sodium-glucose co-transporter-2 inhibitors and other diabetes medications (other glucose lowering drugs) in 2015-17 based on National Russian Diabetes Registry data
Medical condition
Type 2 Diabetes
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
10000
Study type
Observational
Age
N/A
Date
Study Start Date: 15 Apr 2018
Primary Completion Date: 30 Jun 2018
Study Completion Date: 30 Jun 2018
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jun 2019 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
